Valeant Pharma Attempting To Find A Bottom


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


Valeant Pharmaceuticals Intl Inc (NYSE:VRX) shares are trading lower $0.76 at $11.65 in Tuesday's session and trading lower for the fifth time in its last six sessions (including Tuesday's price action) since releasing its fourth-quarter earnings report before the open on February 28.

Over that time, it has declined from its February 27 close ($16.71) to as low as $11.36 earlier in Tuesday's session. The pace of decline accelerated on Monday when the issue breached its former long-term support level at $13.00.

After a lower open, it could not even reach the lower-end of Monday's range ($12.30), only reaching $12.28 before continuing its move lower. So far, the ensuing decline has taken the issue to $11.36 and it is attempting to rebound.

This marks the lowest level for the issue since it bottomed in September 2009 at $11.14.


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsTechnicalsIntraday UpdateMoversTrading IdeasGeneral